Keyphrases
Doxorubicin
100%
GSK-J4
100%
Anaplastic Thyroid Cancer
100%
KRAS mutant
100%
Thyroid Cancer Cells
25%
Effective Treatment
12%
Inhibitory Effect
12%
Poor Prognosis
12%
Tumor Suppression
12%
Chemotherapy Regimen
12%
Binding Assay
12%
Annexin V
12%
In Vitro Experiment
12%
IC50
12%
Cell Viability Assay
12%
Transwell Migration Assay
12%
Tumor Xenograft Model
12%
In Vitro Inhibition
12%
Wound Healing Assay
12%
Inhibition Rate
12%
Mutant Cell Line
12%
Half Maximal Inhibitory Concentration
12%
Thyroid Cancer Cell Lines
12%
Aggressive Thyroid Cancer
12%
Invasion Ability
12%
Migration Ability
12%
Cell Cycle Assay
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Anaplastic Thyroid Carcinoma
100%
Glycogen Synthase Kinase
100%
Neoplasm
25%
IC50
25%
Viability Assay
12%
Cell Viability
12%
Wound Healing
12%
Chemotherapy Regimens
12%
Lipocortin 5
12%
Thyroid Cancer
12%